IL4R rs1050519: Understanding This Genetic Variant
The rs1050519 variant is a missense genetic change located within the IL4R gene. It has been studied for its potential role in modulating immune signaling and its statistical association with allergic bronchopulmonary disorders and atopic dermatitis.
What each genotype means
Typical IL4R signaling
This genotype represents the common form of the IL4R gene. Research suggests this version of the receptor functions within expected parameters for interleukin-4 and interleukin-13 signaling, which are involved in immune regulation and IgE production.
This is the most common genotype globally, though frequencies vary significantly by ancestral background.
Altered receptor sensitivity
This genotype includes one copy of the G allele, which results in a Gln551Arg amino acid change in the IL4R protein. Some studies have associated this variant with an increased risk of atopic asthma and altered receptor signaling sensitivity, though findings are mixed across different populations and clinical settings.
Carried by a significant portion of the population, with the G allele appearing at a frequency of approximately 8-12% in many global cohorts.
Increased atopic risk profile
This genotype results in the Gln551Arg substitution on both copies of the IL4R gene. While some research links this variant to a higher susceptibility for atopic asthma and related allergic conditions, the evidence is considered limited and may depend on other genetic or environmental factors. Please discuss any concerns regarding allergic symptoms or asthma management with your healthcare provider.
This genotype is less common than the AA or AG configurations, reflecting the lower frequency of the G allele in the general population.
What is rs1050519?
The rs1050519 variant is a single nucleotide polymorphism (SNP) located in the IL4R gene, which provides instructions for making the alpha chain of the interleukin-4 receptor. In genetics, a missense variant means that the change in the DNA sequence results in a different amino acid being incorporated into the protein structure. This specific alteration can potentially influence how the receptor functions or how sensitive it is to signaling molecules. Because this variant is located in a gene critical to the immune system, researchers have investigated whether it contributes to variations in how individuals respond to environmental triggers. It is important to note that the presence of this variant does not guarantee any specific health outcome, as complex traits like allergies are influenced by a combination of many genetic factors, environmental exposures, and lifestyle variables.
The Role of the IL4R Gene
The IL4R gene encodes the interleukin-4 receptor alpha chain, a protein that plays a central role in the immune system. This receptor is part of the signaling pathway for interleukin-4 (IL-4) and interleukin-13 (IL-13), which are cytokines—small proteins that act as messengers between cells. These cytokines are heavily involved in regulating inflammatory responses and the development of allergic reactions. When IL-4 or IL-13 binds to the receptor, it triggers a cascade of signals that influence the behavior of various immune cells, including B cells and T cells. By modulating this pathway, the IL4R gene helps determine the intensity and nature of the body's immune response. Variations in this gene, such as rs1050519, are of interest to scientists because they may subtly alter the efficiency or sensitivity of this signaling process, potentially impacting an individual's susceptibility to immune-mediated conditions.
Research and Evidence Strength
Research into rs1050519 has primarily focused on its statistical associations with atopic conditions, such as atopic dermatitis and allergic bronchopulmonary disorders. The evidence strength for these associations is currently considered limited. While some studies have suggested a link between this variant and altered immune signaling sensitivity, these findings are not always consistent across different study populations or clinical settings. Genetic association studies often identify correlations, but establishing a direct causal link between a single SNP and a complex disease is challenging. Because allergic conditions are multifactorial, the impact of any single genetic variant is typically small. Consequently, current scientific consensus suggests that while rs1050519 is a valid subject of ongoing research, it should not be used as a standalone predictor for clinical diagnosis or disease risk assessment.
Population Frequency
The rs1050519 variant is found across various global populations, with a minor allele frequency (MAF) typically ranging between 0.08 and 0.12. This indicates that the variant is relatively common in the general population, rather than being a rare mutation. Because it is present at these frequencies, it is considered a common genetic polymorphism. Frequency can vary based on ancestral background, and researchers often look at these differences to understand the evolutionary history of the variant. It is important to remember that having a common variant does not imply that it is harmful; many common genetic changes are neutral and simply represent the natural diversity found within the human genome.
Interpreting Your Genetic Information
If you have received information about your rs1050519 genotype, it is important to view it within the context of your overall health. This variant is not a diagnostic tool, and its association with health traits is based on population-level statistics rather than individual certainty. You cannot use this information to predict the development of allergies or to make decisions about medical treatments. If you have concerns about allergic symptoms, skin conditions, or immune health, the most appropriate step is to consult with a qualified healthcare provider or an allergist. They can evaluate your symptoms, medical history, and environmental factors to provide personalized care. Never change or stop any medication based on genetic test results without first discussing it with your clinician or pharmacist, as they are best equipped to interpret how your unique genetic profile might interact with your specific health needs.
How common is this variant?
The rs1050519 variant has a minor allele frequency of approximately 0.08 to 0.12 across global populations, making it a common genetic polymorphism.
Frequently asked questions
Is rs1050519 a cause of allergies?
No, rs1050519 is not considered a direct cause of allergies. It is a genetic variant that has been statistically associated with certain allergic traits in some studies, but allergies are complex conditions influenced by many genes and environmental factors.
Should I be worried if I have the GG genotype?
No, you should not be worried. Having a specific genotype for this variant does not mean you will develop a disease, as the evidence linking it to health outcomes is limited and the effect size is generally small.
Can I use this SNP to diagnose atopic dermatitis?
No, this SNP cannot be used for diagnosis. Clinical diagnosis of atopic dermatitis is based on physical examination and medical history, not on genetic testing of a single variant.
Where can I find more information on IL4R?
You can find reliable information on the IL4R gene through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database. These sites provide comprehensive summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1050519?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL4R
A polymorphism modulating IL-4 and IL-13 signaling thresholds on mucosal surfaces, conferring altered predisposition to aeroallergen reactivity.
Variant in the IL4R locus associated with atopic dermatitis and allergic rhinitis susceptibility.
A well-characterized functional missense variant (I50V) in the IL-4 receptor alpha chain that enhances downstream allergic and Th2 signaling pathways.
Missense variant (p.Gln551Arg) in interleukin 4 receptor subunit alpha strongly linked to atopic asthma and IgE regulation.
A functional variant within the IL4R promoter/intron region modulating receptor density and susceptibility to atopic eczema and allergic rhinitis.
A coding missense variant (Q576R) in the IL-4 receptor alpha chain that potentiates downstream STAT6 signaling, increasing predisposition to atopic asthma and severe allergic sensitization.